Published in Clin Chem Lab Med on February 15, 2012
Chronic kidney disease following acute kidney injury-risk and outcomes. Nat Rev Nephrol (2012) 1.39
Diagnostic and prognostic utilities of multimarkers approach using procalcitonin, B-type natriuretic peptide, and neutrophil gelatinase-associated lipocalin in critically ill patients with suspected sepsis. BMC Infect Dis (2014) 0.94
Role of new biomarkers: functional and structural damage. Crit Care Res Pract (2013) 0.90
Plasma Neutrophil Gelatinase-Associated Lipocalin Is Primarily Related to Inflammation during Sepsis: A Translational Approach. PLoS One (2015) 0.88
Impact of sepsis-associated cytokine storm on plasma NGAL during acute kidney injury in a model of polymicrobial sepsis. Crit Care (2013) 0.88
Contrast Medium-Induced Acute Kidney Injury. Cardiorenal Med (2015) 0.79
Neutrophil gelatinase-associated lipocalin (NGAL) predicts the occurrence of malaria-induced acute kidney injury. Malar J (2016) 0.78
Urinary neutrophil gelatinase-associated lipocalin time course during cardiac surgery. Ann Card Anaesth (2015) 0.77
A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) (2016) 0.76
Catheter-based induction of renal ischemia/reperfusion in swine: description of an experimental model. Physiol Rep (2014) 0.76
Effect of Kidney Function on Drug Kinetics and Dosing in Neonates, Infants, and Children. Clin Pharmacokinet (2015) 0.76
Significance of Neutrophil Gelatinase-Associated Lipocalin Level-to-Serum Creatinine Ratio for Assessing Severity of Inflammation in Patients with Renal Dysfunction. Biomed Res Int (2015) 0.75
The serum heart-type fatty acid-binding protein (HFABP) levels can be used to detect the presence of acute kidney injury on admission in patients admitted to the non-surgical intensive care unit. BMC Cardiovasc Disord (2016) 0.75
Role of point of care - ST2, Galectin-3 and adrenomedullin in the evaluation and treatment of emergency patients. Int J Crit Illn Inj Sci (2014) 0.75
Dynamic Changes of Plasma Neutrophil Gelatinase-Associated Lipocalin Predicted Mortality in Critically Ill Patients with Systemic Inflammatory Response Syndrome. Indian J Crit Care Med (2017) 0.75
Accuracy of Urinary Neutrophil Gelatinase-Associated Lipocalin in Quantifying Acute Kidney Injury after Partial Nephrectomy in Patients with Normal Contralateral Kidney. PLoS One (2015) 0.75
Urine/Plasma Neutrophil Gelatinase Associated Lipocalin Ratio Is a Sensitive and Specific Marker of Subclinical Acute Kidney Injury in Mice. PLoS One (2016) 0.75
Clinical utility of urine neutrophil gelatinase-associated lipocalin measured at admission to predict outcomes in heterogeneous population of critically ill patients. Indian J Nephrol (2016) 0.75
Rapid Detection of Acute Kidney Injury by Urinary Neutrophil Gelatinase-Associated Lipocalin in Patients Undergoing Cardiopulmonary Bypass. Turk J Anaesthesiol Reanim (2014) 0.75
Neutrophil gelatinase‑associated lipocalin as a potential novel biomarker for ventilator‑associated lung injury. Mol Med Rep (2017) 0.75
Plasma Neutrophil Gelatinase-Associated Lipocalin as a Predictor of Cardiovascular Events in Patients with Chronic Kidney Disease. Biomed Res Int (2016) 0.75
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (2007) 29.89
Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA (2005) 19.57
An assessment of the RIFLE criteria for acute renal failure in hospitalized patients. Crit Care Med (2006) 6.87
Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA (2009) 6.55
Acute kidney injury. Lancet (2012) 4.90
The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury: a multicenter pooled analysis of prospective studies. J Am Coll Cardiol (2011) 4.57
Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol (2007) 3.17
Diuretics and mortality in acute renal failure. Crit Care Med (2004) 3.12
A wearable haemodialysis device for patients with end-stage renal failure: a pilot study. Lancet (2007) 3.04
Continuous renal replacement therapy: a worldwide practice survey. The beginning and ending supportive therapy for the kidney (B.E.S.T. kidney) investigators. Intensive Care Med (2007) 3.03
Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med (2015) 2.97
Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med (2005) 2.85
Effect of membrane permeability on survival of hemodialysis patients. J Am Soc Nephrol (2008) 2.76
Defining acute renal failure: physiological principles. Intensive Care Med (2003) 2.69
External validation of severity scoring systems for acute renal failure using a multinational database. Crit Care Med (2005) 2.68
Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis. Gut (2011) 2.65
Discontinuation of continuous renal replacement therapy: a post hoc analysis of a prospective multicenter observational study. Crit Care Med (2009) 2.58
A comparison of observed versus estimated baseline creatinine for determination of RIFLE class in patients with acute kidney injury. Nephrol Dial Transplant (2009) 2.55
Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population. Intensive Care Med (2009) 2.53
North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): targeting the problem with the RIFLE Criteria. Clin J Am Soc Nephrol (2007) 2.50
Timing of renal replacement therapy and clinical outcomes in critically ill patients with severe acute kidney injury. J Crit Care (2008) 2.36
Fluid balance and acute kidney injury. Nat Rev Nephrol (2009) 2.23
The pathogenesis of septic acute renal failure. Curr Opin Crit Care (2003) 2.16
Precision and accuracy of a procedure for detecting recent human immunodeficiency virus infections by calculating the antibody avidity index by an automated immunoassay-based method. J Clin Microbiol (2002) 2.11
Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury. Crit Care (2009) 2.03
Clinical review: RIFLE and AKIN--time for reappraisal. Crit Care (2009) 2.00
Classification and staging of acute kidney injury: beyond the RIFLE and AKIN criteria. Nat Rev Nephrol (2011) 1.99
Prevention of acute kidney injury and protection of renal function in the intensive care unit. Expert opinion of the Working Group for Nephrology, ESICM. Intensive Care Med (2010) 1.98
Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant (2013) 1.96
Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med (2006) 1.91
The first international consensus conference on continuous renal replacement therapy. Kidney Int (2002) 1.89
Oliguria as predictive biomarker of acute kidney injury in critically ill patients. Crit Care (2011) 1.86
Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered key questions. Clin J Am Soc Nephrol (2008) 1.82
Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care (2007) 1.80
Practice patterns in the management of acute renal failure in the critically ill patient: an international survey. Nephrol Dial Transplant (2005) 1.78
Identifying recent HIV infections using the avidity index and an automated enzyme immunoassay. J Acquir Immune Defic Syndr (2003) 1.74
Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med (2005) 1.69
Fluid balance as a biomarker: impact of fluid overload on outcome in critically ill patients with acute kidney injury. Crit Care (2008) 1.64
A phase II randomized, controlled trial of continuous hemofiltration in sepsis. Crit Care Med (2002) 1.61
Subclinical AKI is still AKI. Crit Care (2012) 1.59
Arteriovenous fistula toxicity. Blood Purif (2011) 1.57
Early diagnosis of acute kidney injury: the promise of novel biomarkers. Blood Purif (2009) 1.55
Kidney attack. JAMA (2012) 1.46
Copeptin and high sensitive troponin for a rapid rule out of acute myocardial infarction? Clin Lab (2011) 1.43
Improving outcomes from acute kidney injury. J Am Soc Nephrol (2007) 1.42
Docosahexaenoic acid supplementation decreases liver fat content in children with non-alcoholic fatty liver disease: double-blind randomised controlled clinical trial. Arch Dis Child (2011) 1.42
Consensus development in acute renal failure: The Acute Dialysis Quality Initiative. Curr Opin Crit Care (2005) 1.40
Biosimilars and safety issues. Leuk Lymphoma (2009) 1.40
Do not dialyze. Int J Artif Organs (2006) 1.40
Primary prevention of acute renal failure in the critically ill. Curr Opin Crit Care (2005) 1.40
Definition and classification of acute kidney injury. Nephron Clin Pract (2008) 1.39
Oxidative stress and 'monocyte reprogramming' in septic patients with acute kidney injury requiring CRRT. Blood Purif (2008) 1.39
Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients. Interact Cardiovasc Thorac Surg (2009) 1.38
Evaluation of bilirubin concentration in hemolysed samples, is it really impossible? The altitude-curve cartography approach to interfered assays. Clin Chim Acta (2011) 1.38
Improving outcomes of acute kidney injury: report of an initiative. Nat Clin Pract Nephrol (2007) 1.38
Diagnosis of acute kidney injury using functional and injury biomarkers: workgroup statements from the tenth Acute Dialysis Quality Initiative Consensus Conference. Contrib Nephrol (2013) 1.37
Cardiopulmonary bypass-associated acute kidney injury: a pigment nephropathy? Contrib Nephrol (2007) 1.34
Epidemiology of acute kidney injury. Contrib Nephrol (2010) 1.33
A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem (2004) 1.30
Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified Delphi process. Clin J Am Soc Nephrol (2008) 1.30
Subclinical AKI--an emerging syndrome with important consequences. Nat Rev Nephrol (2012) 1.29
Pre-renal azotemia: a flawed paradigm in critically ill septic patients? Contrib Nephrol (2007) 1.29
Fluid balance and urine volume are independent predictors of mortality in acute kidney injury. Crit Care (2013) 1.29
Improving outcomes from acute kidney injury: report of an initiative. Am J Kidney Dis (2007) 1.26
Quantitative analysis of HBsAg, IgM anti-HBc and anti-HBc avidity in acute and chronic hepatitis B. J Clin Virol (2006) 1.22
Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant (2010) 1.22
NGAL: a biomarker of acute kidney injury and other systemic conditions. Int Urol Nephrol (2009) 1.22
HE4 and epithelial ovarian cancer: comparison and clinical evaluation of two immunoassays and a combination algorithm. Clin Chim Acta (2011) 1.18
Improving outcomes from acute kidney injury: report of an initiative. Pediatr Nephrol (2007) 1.15
Fat and fatty acid terminology, methods of analysis and fat digestion and metabolism: a background review paper. Ann Nutr Metab (2009) 1.15
Acute kidney injury: classification and staging. Contrib Nephrol (2010) 1.14
Postprandial anti-inflammatory and antioxidant effects of extra virgin olive oil. Atherosclerosis (2006) 1.13
In vivo validation of the adequacy calculator for continuous renal replacement therapies. Crit Care (2005) 1.12
Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.11
Patient Selection and Timing of Continuous Renal Replacement Therapy. Blood Purif (2016) 1.10
Biological properties of olive oil phytochemicals. Crit Rev Food Sci Nutr (2002) 1.10
RIFLE criteria for cardiac surgery-associated acute kidney injury: risk factors and outcomes. Congest Heart Fail (2010) 1.10
Hospital-acquired acute kidney injury in the elderly. Nat Rev Nephrol (2010) 1.10
Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: concordance and correlation with cytological results. J Clin Virol (2002) 1.09
Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. Crit Care (2005) 1.08
Fluid overload in critically ill patients with acute kidney injury. Blood Purif (2010) 1.08
Application of body composition monitoring to peritoneal dialysis patients. Contrib Nephrol (2009) 1.07
Acute peritoneal dialysis: what is the 'adequate' dose for acute kidney injury? Nephrol Dial Transplant (2010) 1.07
Use of peritoneal dialysis in AKI: a systematic review. Clin J Am Soc Nephrol (2013) 1.07
The best dialysis therapy? Results from an international survey among nephrology professionals. NDT Plus (2008) 1.07
Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. Nephrol Dial Transplant (2010) 1.07
RIFLE-based data collection/management system applied to a prospective cohort multicenter Italian study on the epidemiology of acute kidney injury in the intensive care unit. Blood Purif (2011) 1.05
Hepatitis C virus core antigen: analytical performances, correlation with viremia and potential applications of a quantitative, automated immunoassay. J Clin Virol (2011) 1.04
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. Cancer Epidemiol Biomarkers Prev (2011) 1.04
The implications and management of septic acute kidney injury. Nat Rev Nephrol (2011) 1.04
Determination of serum holotranscobalamin concentrations with the AxSYM active B(12) assay: cut-off point evaluation in the clinical laboratory. Clin Chem Lab Med (2010) 1.04
Pathophysiology of the cardiorenal syndromes: executive summary from the eleventh consensus conference of the Acute Dialysis Quality Initiative (ADQI). Contrib Nephrol (2013) 1.03
CA.R.PE.DI.E.M. (Cardio-Renal Pediatric Dialysis Emergency Machine): evolution of continuous renal replacement therapies in infants. A personal journey. Pediatr Nephrol (2012) 1.03
Avidity Index for anti-HIV antibodies: comparison between third- and fourth-generation automated immunoassays. J Clin Microbiol (2011) 1.03
Heart-kidney crosstalk and role of humoral signaling in critical illness. Crit Care (2014) 1.02
Renal functional reserve and renal recovery after acute kidney injury. Nephron Clin Pract (2014) 1.01
Modalities of continuous renal replacement therapy: technical and clinical considerations. Semin Dial (2009) 1.00
Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids. Lipids (2003) 1.00
Timing, dose and mode of dialysis in acute kidney injury. Curr Opin Crit Care (2011) 1.00